Olaparib +/- Cediranib or Chemotherapy in Patients With Platinum-resistant Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to AstraZeneca
Related studies linked through entity extraction aliases.
Neoadjuvant Durvalumab and Tremelimumab Plus Radiation for High Risk Soft-Tissue Sarcoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Targeting Iatrogenic Cushing's Syndrome With 11β-hydroxysteroid Dehydrogenase Type 1 Inhibition
- Status
- COMPLETED
- Phase
- PHASE2
Olaparib & Radiation Therapy for Patients Triple Negative Breast Cancer (TNBC)
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Examine Olaparib Maintenance Retreatment in Patients With Epithelial Ovarian Cancer.
- Status
- COMPLETED
- Phase
- PHASE3
Vistusertib (AZD2014) Monotherapy in Relapsed Small Cell Lung Cancer Patients Harboring RICTOR Amplification
- Status
- TERMINATED
- Phase
- PHASE2
Phase I Dose-Escalation Study of AZD4785 in Patients With Advanced Solid Tumours
- Status
- COMPLETED
- Phase
- PHASE1
Pattern of Repeat Cardiovascular Events During Follow-up After First Diagnosed Event-MI
- Status
- UNKNOWN
- Phase
- N/A
A Study of the Pharmacokinetic and Pharmacodynamic Responses in Healthy and Altered Human Cardiovascular Systems
- Status
- TERMINATED
- Phase
- PHASE1
PET Study to Determine Muscarinic Receptor Occupancy in Lungs After Inhalation of AZD2115 and Tiotropium
- Status
- COMPLETED
- Phase
- PHASE1
Trial of Selumetinib in Patients With Neurofibromatosis Type II Related Tumors
- Status
- TERMINATED
- Phase
- PHASE2
Savolitinib vs. Sunitinib in MET-driven PRCC.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A 6-month Clinical Study to Evaluate the Effect of a Digital Disease Management Tool in Patients With T2DM
- Status
- COMPLETED
- Phase
- N/A
Trabectedin Combined With Durvalumab in Patients With Advanced Pretreated Soft-tissue Sarcomas and Ovarian Carcinomas.
- Status
- COMPLETED
- Phase
- PHASE1
Retrospective Study of Patients With Type 2 Diabetes Mellitus on Dapagliflozin Therapy in Taiwan
- Status
- COMPLETED
- Phase
- N/A
An Open-Label, Multi-Centre, Study to Assess the Safety of Fixed-Dose Durvalumab + Tremelimumab Combination Therapy or Durvalumab Monotherapy in Advanced Solid Malignancies.
- Status
- COMPLETED
- Phase
- PHASE3
Prevalence of BRCA1 and BRCA2 Mutations in Ovarian Cancer Patients in the Gulf Region
- Status
- COMPLETED
- Phase
- N/A
Durvalumab Alone or With Tremelimumab in Refractory Germ Cell Tumors
- Status
- TERMINATED
- Phase
- PHASE2
Expanded Access Program for Olaparib Tablets as Maintenance Therapy in Patients With Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
Characteristics of Patients With Type 2 Diabetes Mellitus Receiving Treatment With Dapagliflozin Versus Sitagliptin: An Analysis of Commercial Claims and Linked Laboratory Data
- Status
- COMPLETED
- Phase
- N/A